CCEP’s vice president for sustainability Joe Franses stated: “Innovation is a key principle of our sustainable packaging work and the application of this fully recyclable paperboard KeelClip, which comprises a top board that the cans clip into and a central cardboard ‘keel’ – similar to a ship’s keel – that stabilizes the pack, is another example of how we are delivering on our commitment to remove all unnecessary and hard to recycle single-use plastic from our products.”Reportedly in September, CCEP declared it would end the use of shrink-wrapped plastics across all can multipacks in Great Britain and replace the packaging with 100% recyclable cardboard from Forest Stewardship Council (FSC) or Programme for the Endorsement of Forest Certification (PEFC) certified sources. Coca-Cola intends to make all bottles globally with an average of 50% recycled content by 2030 after the company was named as the world’s largest corporate plastic polluter last year with three million tonnes of plastic usage in its global operations in 2018. To learn more about The Coca-Cola Company (KO) and to continue to track its progress please visit the Vista Partners Coca-Cola Company Coverage Page.
“We are extremely pleased to receive this very important product certification, the CE Mark, which permits us to commercially distribute the world’s only in vivo fertilization treatment to the millions of patients throughout the countries of the EU. The European countries represent a large potential market for INVOcell, with an estimated $3 to $4 billion currently spent on IVF treatments. Importantly, INVOcell is a simple and more natural solution with the potential to expand the overall addressable market for treatment due to its ability to lower costs compared to IVF while also demonstrating comparable rates of effectiveness. We are currently in the middle of active discussions with several distribution partners around the world, including within the European market, and look forward to providing updates on our international efforts in the near future”, stated Steve Shum, CEO of INVO Bioscience.
Please read the complete story now!